S
Steven H. Swerdlow
Researcher at University of Pittsburgh
Publications - 225
Citations - 16016
Steven H. Swerdlow is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Lymphoma & Chronic lymphocytic leukemia. The author has an hindex of 57, co-authored 209 publications receiving 14435 citations. Previous affiliations of Steven H. Swerdlow include University of Cincinnati & University of Cincinnati Academic Health Center.
Papers
More filters
Journal ArticleDOI
WHO-EORTC classification for cutaneous lymphomas.
Rein Willemze,Elaine S. Jaffe,Günter Burg,Lorenzo Cerroni,Emilio Berti,Steven H. Swerdlow,Elisabeth Ralfkiaer,Sergio Chimenti,José Luis Diaz-Perez,Lyn M. Duncan,Florent Grange,Nancy L. Harris,Werner Kempf,Helmut Kerl,Michael O. Kurrer,Robert Knobler,Nicola Pimpinelli,Chris Sander,Marco Santucci,Wolfram Sterry,Maarten H. Vermeer,Janine Wechsler,Sean Whittaker,Chris J.L.M. Meijer +23 more
TL;DR: The characteristic features of the different primary cutaneous lymphomas and other hematologic neoplasms frequently presenting in the skin are described, and differences with the previous classification schemes are discussed.
Journal ArticleDOI
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.
TL;DR: The criteria and significance of early or precursor lesions and the identification of certain lymphoid neoplasms largely associated with particular age groups, such as children and the elderly are addressed, and the issue of borderline categories having overlapping features with large B-cell lymphomas is reviewed.
Journal ArticleDOI
Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma
Verònica Fernàndez,Olga Salamero,Blanca Espinet,Francesc Solé,Cristina Royo,Alba Navarro,Francisca I. Camacho,Sílvia Beà,Elena Hartmann,Virginia Amador,Luis Hernández,Claudio Agostinelli,Rachel L. Sargent,María Rozman,Marta Aymerich,Dolors Colomer,Neus Villamor,Steven H. Swerdlow,Stefano Pileri,Francesc Bosch,Miguel A. Piris,Emili Montserrat,German Ott,Andreas Rosenwald,Armando López-Guillermo,Pedro Jares,Sergi Serrano,Elias Campo +27 more
TL;DR: Nonnodal presentation, predominantly hypermutated IGVH, lack of genomic complexity, and absence of SOX11 expression are defined as qualities of a specific subtype of iMCL with excellent outcomes that might be managed more conservatively than cMCL.
Journal ArticleDOI
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes
Edgardo R. Parrilla Castellar,Elaine S. Jaffe,Jonathan W. Said,Steven H. Swerdlow,Rhett P. Ketterling,Ryan A. Knudson,Jagmohan S. Sidhu,Eric D. Hsi,Shridevi Karikehalli,Liuyan Jiang,George Vasmatzis,Sarah E. Gibson,Sarah L. Ondrejka,Alina Nicolae,Karen L. Grogg,Cristine Allmer,Kay M. Ristow,Wyndham H. Wilson,William R. Macon,Mark E. Law,James R. Cerhan,Thomas M. Habermann,Stephen M. Ansell,Ahmet Dogan,Matthew J. Maurer,Andrew L. Feldman +25 more
TL;DR: ALK-negative ALCL is a genetically heterogeneous disease with widely disparate outcomes following standard therapy, and DUSP22 and TP63 rearrangements may serve as predictive biomarkers to help guide patient management.
Journal ArticleDOI
Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors.
Masahiro Shuda,Reety Arora,Hyun Jin Kwun,Huichen Feng,Ronit Sarid,María Teresa Fernández-Figueras,Yanis L. Tolstov,Ole Gjoerup,Mahesh Mansukhani,Steven H. Swerdlow,Preet M. Chaudhary,John M. Kirkwood,Michael A. Nalesnik,Jeffrey A. Kant,Lawrence M. Weiss,Patrick S. Moore,Yuan Chang +16 more
TL;DR: A monoclonal antibody is developed that specifically recognizes endogenous and transfected MCV large T (LT) antigen and expression of this putative viral oncoprotein in tumor cells provides the mechanistic underpinning supporting the notion that MCV causes a subset of MCC.